Sprycel 70 mg

SPRYCEL 70 MG tablets contain dasatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Bristol-Myers Squibb Canada and is available in a 60-tablet pack.

SPRYCEL 70 MG tablets are primarily used in the treatment of specific types of leukemia and other cancers. Dasatinib, the active ingredient, is often prescribed for conditions where targeted therapy is required. Patients may wonder, 'What is dasatinib used for?' and the answer is that it is typically used in the management of chronic myeloid leukemia and acute lymphoblastic leukemia.

Common effects of SPRYCEL 70 MG tablets may include fatigue, nausea, and skin rashes. Some users might experience more severe side effects, and it is important to monitor any unusual symptoms. The effects can vary from person to person, and not everyone will experience the same reactions.

SPRYCEL 70 MG tablets should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding the use of this medication. Precautions should be taken to avoid missing doses and to manage any side effects that may arise.

SPRYCEL 70 MG tablets may interact with certain medications, including those that affect liver enzymes. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol and other substances may also interact with dasatinib, so caution is advised.